Page last updated: 2024-08-23

phosphotyrosine and Prostatic Neoplasms, Castration-Resistant

phosphotyrosine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drake, JM; Faltermeier, CM; Graeber, TG; Graham, NA; Huang, J; Lee, JK; Pienta, KJ; Stoyanova, T; Sud, S; Titz, B; Witte, ON	1

Other Studies

1 other study(ies) available for phosphotyrosine and Prostatic Neoplasms, Castration-Resistant

Article	Year
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proceedings of the National Academy of Sciences of the United States of America, 2013, Dec-03, Volume: 110, Issue:49 Topics: Blotting, Western; Cell Line, Tumor; Drug Discovery; Enzyme Activation; ErbB Receptors; Humans; Male; Mass Spectrometry; Neoplasm Metastasis; Phosphoproteins; Phosphorylation; Phosphotyrosine; Precision Medicine; Principal Component Analysis; Prostatic Neoplasms, Castration-Resistant; Protein-Tyrosine Kinases	2013

Article

Year

Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.

Proceedings of the National Academy of Sciences of the United States of America, 2013, Dec-03, Volume: 110, Issue:49

Topics: Blotting, Western; Cell Line, Tumor; Drug Discovery; Enzyme Activation; ErbB Receptors; Humans; Male; Mass Spectrometry; Neoplasm Metastasis; Phosphoproteins; Phosphorylation; Phosphotyrosine; Precision Medicine; Principal Component Analysis; Prostatic Neoplasms, Castration-Resistant; Protein-Tyrosine Kinases

2013